The SIRPa-Fc-CD40L ARC fusion protein (SL-172154) is a bifunctional fusion protein that blocks CD47/SIRPa on tumour cells and CD40/CD40L on immune antigen-presenting cells. Here, CD40LG is linked to neoplasm.